Growth Metrics

Merck (MRK) Capital Expenditures Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.74%
Dec 31, 2025 -6.31%
Sep 30, 2025 26.72%
Jun 30, 2025 6.15%
Mar 31, 2025 6.14%
Dec 31, 2024 -1.93%
Sep 30, 2024 -3.97%
Jun 30, 2024 0.23%
Mar 31, 2024 7.67%
Dec 31, 2023 1.26%
Sep 30, 2023 6.67%
Jun 30, 2023 10.60%
Mar 31, 2023 17.48%
Dec 31, 2022 9.95%
Sep 30, 2022 20.62%
Jun 30, 2022 23.50%
Mar 31, 2022 23.75%
Dec 31, 2021 17.00%
Sep 30, 2021 23.44%
Jun 30, 2021 21.33%
Mar 31, 2021 31.14%
Dec 31, 2020 23.75%
Sep 30, 2020 -0.90%
Jun 30, 2020 15.91%
Mar 31, 2020 37.18%
Dec 31, 2019 16.09%
Sep 30, 2019 24.55%
Jun 30, 2019 20.96%
Mar 31, 2019 23.75%
Dec 31, 2018 16.71%
Sep 30, 2018 12.96%
Jun 30, 2018 7.14%
Mar 31, 2018 5.09%
Dec 31, 2017 -1.67%
Sep 30, 2017 1.27%
Jun 30, 2017 -1.83%
Mar 31, 2017 0.48%
Dec 31, 2016 -1.79%
Sep 30, 2016 -1.04%
Jun 30, 2016 0.54%
Mar 31, 2016 -2.95%
Dec 31, 2015 -5.67%
Sep 30, 2015 -1.34%
Jun 30, 2015 -4.27%
Mar 31, 2015 -9.96%
Dec 31, 2014 -2.54%
Sep 30, 2014 1.08%
Jun 30, 2014 -3.73%
Mar 31, 2014 -2.70%